These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 5566767)
21. Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. Harbison RD; Mantilla-Plata B J Pharmacol Exp Ther; 1972 Feb; 180(2):446-53. PubMed ID: 5010682 [No Abstract] [Full Text] [Related]
22. Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. Hill DL; Laster WR; Struck RF Cancer Res; 1972 Apr; 32(4):658-65. PubMed ID: 5014778 [No Abstract] [Full Text] [Related]
27. Effects of pretreatment with SKF-525A or sodium phenobarbital on thiabendazole-induced teratogenicity in ICR mice. Ogata A; Yoneyama M; Sasaki M; Suzuki K; Imamichi T Food Chem Toxicol; 1987 Feb; 25(2):119-24. PubMed ID: 3557233 [TBL] [Abstract][Full Text] [Related]
28. Attempts to induce drug metabolism in human fetal liver and placenta by the administration of phenobarbital to mothers. Pelkonen O; Jouppila P; Kärki NT Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):288-97. PubMed ID: 4694366 [No Abstract] [Full Text] [Related]
29. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. Hales BF Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774 [TBL] [Abstract][Full Text] [Related]
30. [Pecularities of placental barrier permeability and distribution of ristomycin sulfate in the blood and organs of albino mice under conditions of sensitization with homoplacental protein]. Buniatova IM Antibiotiki; 1972 Jul; 17(7):634-8. PubMed ID: 4347623 [No Abstract] [Full Text] [Related]
32. Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice. Hart LG; Adamson RH Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):391-401. PubMed ID: 5348409 [No Abstract] [Full Text] [Related]
33. The effect of phenobarbital and SKF 525A on tocainide pharmacokinetics in the rat. Venkataramanan R; Axelson JE J Pharmacol Exp Ther; 1980 Oct; 215(1):235-9. PubMed ID: 6778991 [TBL] [Abstract][Full Text] [Related]
34. [Dosage and adverse effect problems in pregnancy]. Kuemmerle HP Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):356-9. PubMed ID: 5148893 [No Abstract] [Full Text] [Related]
35. Bidirectional transfer of methadone across human placenta. Nekhayeva IA; Nanovskaya TN; Deshmukh SV; Zharikova OL; Hankins GD; Ahmed MS Biochem Pharmacol; 2005 Jan; 69(1):187-97. PubMed ID: 15588727 [TBL] [Abstract][Full Text] [Related]
36. Studies on the pharmacokinetics of cyclophosphamide in sheep. Schaumlöffel E; Habermehl A; Brock N; Schneider B Arzneimittelforschung; 1973 Apr; 23(4):491-500. PubMed ID: 4740226 [No Abstract] [Full Text] [Related]
37. Ex vivo human placental transfer of trovafloxacin. Casey B; Bawdon RE Infect Dis Obstet Gynecol; 2000; 8(5-6):228-9. PubMed ID: 11220482 [TBL] [Abstract][Full Text] [Related]
38. Placental passage of metformin in women with polycystic ovary syndrome. Vanky E; Zahlsen K; Spigset O; Carlsen SM Fertil Steril; 2005 May; 83(5):1575-8. PubMed ID: 15866611 [TBL] [Abstract][Full Text] [Related]
39. Transplacental pharmacokinetics of diclofenac in perfused human placenta. Shintaku K; Hori S; Tsujimoto M; Nagata H; Satoh S; Tsukimori K; Nakano H; Fujii T; Taketani Y; Ohtani H; Sawada Y Drug Metab Dispos; 2009 May; 37(5):962-8. PubMed ID: 19204082 [TBL] [Abstract][Full Text] [Related]
40. Metabolism of 16alpha-hydroxy-pregnenolone and 17alpha-hydroxy-pregnenolone in the foeto-placental unit and mother at midgestation. Reynolds JW; Wiqvist N; Diczfalusy E Acta Endocrinol (Copenh); 1969 Jul; 61(3):533-50. PubMed ID: 5820062 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]